This webinar will provide attendees with the latest evidence for the benefits and potential harms of PSA testing, enhance knowledge of PSA testing guidelines and identification of patients for urological investigation, develop confidence in participating in PSA testing shared decision making and share practical guidance for managing side effects of prostate cancer hormonal therapies.
When: Wednesday, 26 August 2020
Time: 7:00pm – 8:15pm
Register: https://webstreamlive.com/astrazeneca/au/26aug20
SPEAKER: PROFESSOR DAVID GILLATT
MB ChB FRCS FRCS(E) FRCS (Urol) FRACS ChM
Professor of Urological Oncology & Robotics, and Director of Medical Services,
Macquarie University Hospital
More details: view flyer